27 Nov 2025

Setterwalls Advises Doktor.se on Approximately SEK 250 Million Share Issue

"Setterwalls advised Doktor.se on a share issue of approximately SEK 250 million, comprising a SEK 200 million rights issue and a SEK 50 million over‑allotment following oversubscription. Proceeds will enhance financial flexibility for acquisitions and general purposes. Doktor.se plans to seek a listing in Q4 2026–Q1 2027."

Setterwalls represented Doktor.se in connection with a share issue of approximately SEK 250 million. Doktor.se carried out a share issue of approximately SEK 250 million, consisting of a rights issue of approximately SEK 200 million and, as a result of the oversubscription of the rights issue, an over‑allotment issue of SEK 50 million. The net proceeds from the rights issue and the over‑allotment will be used to enhance the company’s financial flexibility for executing acquisitions and for ongoing general business purposes. Doktor.se, one of Europe’s largest market players in digital and physical healthcare, operates in Sweden, Germany, Finland and Norway and plans to expand into additional European countries in the coming years. The company intends to apply for listing of its shares on Nasdaq Stockholm or another suitable marketplace during Q4 2026–Q1 2027, provided conditions are favorable from an operational and market perspective. Setterwalls represented Doktor.se with a team composed by: Marcus Nivinger, Johanna Linnarsson, Anna Barnekow and Tilda Karlsson. The engagement drew on the firm’s expertise in Equity Capital Markets, Corporate Law and IT, Technology and Telecoms.
Read the full story

Register for free to access daily news.

Register Free
We use cookies to improve your experience, analyze traffic, and serve targeted ads. Read our Cookie Policy.

Cookie Preferences

Customize your cookie settings. Necessary cookies are always enabled.

Strictly Necessary

Required for the website to function (e.g. login, security).

Analytics & Statistics

Help us understand how visitors interact with the website.

Marketing & Ads

Used to deliver relevant ads and track effectiveness.